Jeil Pharm (002620) — Free Cash Flow Generation Index
Latest as of December 2025:
-0.15x
Jeil Pharm (002620) has a Free Cash Flow Generation Index of -0.15x as of December 2025. Free cash flow of ₩-290.23 Million represents 0% of operating cash flow (₩1.97 Billion). See Jeil Pharm current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
-0.15x
Free Cash Flow / Operating CF
Free Cash Flow
₩-290.23 Million
KRW
Operating Cash Flow
₩1.97 Billion
KRW
Capital Expenditures
₩2.26 Billion
KRW
Jeil Pharm Free Cash Flow Generation Index (2011–2025)
Historical FCF Generation Index trend for Jeil Pharm across 8 annual periods. Explore debt repayment capacity of Jeil Pharm to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Jeil Pharm (2011–2025)
Year-by-year Free Cash Flow Generation Index for Jeil Pharm. For the full company profile including market capitalisation, see how much is Jeil Pharm worth.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -22.90x | ₩-8.94 Billion | ₩390.26 Million | ₩9.33 Billion | ▼ -4382.3% |
| 2024 | -0.51x | ₩-2.32 Billion | ₩4.54 Billion | ₩6.86 Billion | ▲ +33.7% |
| 2021 | -0.77x | ₩-10.33 Billion | ₩13.40 Billion | ₩23.69 Billion | ▼ -182.5% |
| 2019 | 0.93x | ₩23.56 Billion | ₩25.22 Billion | ₩37.69 Billion | ▲ +87.5% |
| 2017 | 0.50x | ₩2.95 Billion | ₩5.92 Billion | ₩2.94 Billion | ▼ -86.4% |
| 2016 | 3.67x | ₩41.68 Billion | ₩11.36 Billion | ₩30.33 Billion | ▲ +6.2% |
| 2015 | 3.46x | ₩9.48 Billion | ₩2.74 Billion | ₩6.74 Billion | ▲ +77.5% |
| 2011 | 1.95x | ₩46.03 Billion | ₩23.63 Billion | ₩22.40 Billion | — |
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).